Trials / Completed
CompletedNCT02052531
Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus
A Phase II, Single Center, Double-blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of PAC-14028 Cream in Dermal Pruritus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Amorepacific Corporation · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to find a clinically appropriate dose of PAC-14028 cream by comparatively evaluating the efficacy and safety of PAC-14028 cream of Amorepacific Corporation in patients with dermal pruritus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PAC-14028 | Participants received topical PAC-14028 cream 0.3 or 1% twice daily for 4 weeks |
| OTHER | Vehicle | Participants received topical Vehicle twice daily for 4 weeks |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-06-01
- Completion
- 2013-07-01
- First posted
- 2014-02-03
- Last updated
- 2015-09-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02052531. Inclusion in this directory is not an endorsement.